| Write You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Loans > Loans UK - Loans for Everybody |
|
Write You - Loans UK - Loans for Everybody
Loans UK are broadly of two types: secured loans and unsecured loans. Secured loans are given b According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product y the lender against the collateral furnished by the borrower. The collateral could be anything ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in , from a house to jewelery. In fact, the loan amount is dependent on the equity present in the lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. collateral. With unsecured loans, there is no need for the borrower to put up collateral as se here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe curity. The money that can be had with this loan is lower than secured loans. There are advanta d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ges and disadvantages of secured and unsecured loans. The benefits with a secured loan are man ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc y. With a secured loan, the borrower gets a bigger loan amount and relatively lesser interest r easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ate. The toning down of the interest rate is mainly due to the presence of collateral. With col nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically lateral in place, the lender faces lesser risk. He can always recoup the loan amount by selling and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ off the collateral in the case of a repayment default. With an unsecured loan, one get ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s a totally different set of benefits. The obvious advantage is that there is no need for the l ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a oan taker to risk collateral. Secondly, the documentation process that accompanies secured loan dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod s is greatly alleviated in this case. There are some disadvantages to unsecured loans. With th cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ese loans, the amount one can borrow is lesser. Also, with collateral not present, the interest tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Shells - How They Can Save Your Business Thousands Of Dollars Is Blogging A Hard Slog? Keeping the Faith Until the Tide Turns
|